Condition
Neutropenia (Low White Blood Cell Count) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neutropenia (Low White Blood Cell Count) clinical trials that are recruiting, at sites in 2 countries (most in Israel (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Leucogen to prevent ribociclib-related low white blood cell counts in early breast cancer
This trial will test whether taking leucogen reduces the chance of severe neutropenia in women with early HR-positive/HER2-negative breast cancer who are starting ribociclib with endocrine therapy.
-
Assessing ethnic neutropenia and Duffy null phenotype in newborns
This study is trying to see how common a specific genetic trait related to low white blood cell counts is in newborns at Kaplan Medical Center and how it connects to their ethnicity and health over time.
Related topics
Quick answers
How many Neutropenia (Low White Blood Cell Count) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Israel (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.